spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  BioDelivery Sciences 

 HSMN NewsFeed - 27 Feb 2019
Eiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2018
PDL BioPharma Names Edward Imbrogno Vice President of Finance
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 4 Jun 2018
RDD Pharma Appoints Dr. Mark Sirgo as Board Chairman
Biopharmaceuticals Gatroenterology Personnel
 HSMN NewsFeed - 23 Aug 2017
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 12 Jul 2017
BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA(R) In Canada
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Sep 2015
Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., as Senior Vice President and Chief Technology Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Jul 2013
BioDelivery Sciences Announces Regulatory Approval of ONSOLIS in Taiwan
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 Jul 2013
BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Apr 2013
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Feb 2012
US Patent Office Rejects All Claims in Second MonoSol Patent
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 Jan 2012
Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 Jan 2012
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Jul 2009
Meda: Onsolis receives FDA approval
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Jan 2009
Meda Acquires World-Wide Rights to Onsolis
Biopharmaceuticals Distribution
 HSMN NewsFeed - 5 Jan 2009
BioDelivery Sciences Closes $6 Million Transaction with Meda
Biopharmaceuticals Distribution
 HSMN NewsFeed - 6 Feb 2008
Salix Announces Appointment of Mark Sirgo to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2008
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Nov 2007
BioDelivery Sciences International Relocates Corporate Headquarters
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
Biopharmaceuticals Oncology Pain Management
 HSMN NewsFeed - 14 Aug 2007
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Apr 2007
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 10 Apr 2007
BioDelivery Sciences Names Al Medwar as Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2007
BDSI Announces FDA Acceptance of Bioral(R) Amphotericin IND
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Aug 2006
BioDelivery Sciences International and MEDA AB Announce European Licensing Agreement on BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 3 Aug 2006
Meda In-Licenses Innovative Pain Product from The U.S.
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 3 Aug 2006
BDSI Announces Purchase of Non-U.S. BEMA(TM) Technology from QLT USA, Inc.
Biopharmaceuticals Acquisitions Drug Delivery
 HSMN NewsFeed - 9 Jan 2006
BioDelivery Sciences Hires Proven Pharmaceutical Executive To Head Sales and Marketing Effort
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2006
BioDelivery Sciences Files IND for BEMA(TM) LA, a Treatment for Moderate to Severe Pain
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 13

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 13 additional stories matching:
BioDelivery Sciences
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.